Press release
Elevating Prevalence Of Liver Diseases Fuels Growth In Liver Disease Therapeutics Market: Key Factor Driving The Growth In The Liver Diseases Therapeutics Market
Liver Diseases Therapeutics
What Is the Expected Liver Diseases Therapeutics Market Size During the Forecast Period?
The market size for therapeutics for liver diseases has been experiencing robust growth in the past few years. It's projected to rise from $14.16 billion in 2024 to an impressive $15.23 billion in 2025, with a compound annual growth rate (CAGR) of 7.6%. This growth during the historical period is due to factors like a high incidence of liver diseases, patterns of alcohol consumption, developments in diagnostic techniques, obesity and metabolic syndrome conditions, consciousness and screening campaigns, and government-led hepatitis control initiatives.
Expectations are high for substantial expansion in the liver diseases therapeutics market size in the upcoming years. Forecasts predict growth to $20.78 billion by 2029 with a compound annual growth rate (CAGR) of 8.1%. The enhanced growth in the forecast period is due to the adoption of precision medicine methods, advances in RNA therapeutics, an emphasis on fibrosis treatments, patient backing and support groups, hepatitis vaccine developments, and regulatory support for rare disease drugs. Anticipated trends for the forecast period encompass advancements in Hepatitis C treatment, emergence of innovative therapies for liver fibrosis, exploration of immunotherapies, implementation of telemedicine and remote monitoring, and a focus on nutritional interventions.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7969
What Are the High-Growth Segments in the Liver Diseases Therapeutics Market?
The liver diseases therapeutics market covered in this report is segmented -
1) By Disease Type: Hepatitis, Non-Alcoholic Fatty Liver Disease, Alcohol-Induced, Liver Cancer
2) By Treatment: Antiviral, Vaccines, Chemotherapy, Immunosuppressive Agents, Corticosteroids
3) By End User: Hospitals, Ambulatory Surgery Centers, Other End Users
Subsegments:
1) By Hepatitis: Hepatitis A, Hepatitis B, Hepatitis C, Hepatitis D
2) By Non-Alcoholic Fatty Liver Disease (NAFLD): Non-Alcoholic Steatohepatitis (NASH), Simple Fatty Liver
3) By Alcohol-Induced Liver Disease: Alcoholic Hepatitis, Alcoholic Cirrhosis
4) By Liver Cancer: Hepatocellular Carcinoma (HCC), Cholangiocarcinoma
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7969&type=smp
What Key Drivers Are Expected to Influence Future Liver Diseases Therapeutics Market Growth?
The increase in liver disease cases is anticipated to fuel the expansion of the liver disease therapeutics market. Liver disease pertains to any malady that impacts the liver, and these therapeutics offer various methods to treat these liver illnesses. For example, data from the Office for Health Improvement and Disparities, a government agency in the UK, report that the rate of fatalities due to liver disease for those under the age of 75 in England rose to 21.4 per 100,000 people in 2022. Particularly, males had 6,664 early deaths compared to 3,929 for females. Thus, the escalating frequency of liver diseases is fostering the augmentation of the liver disease therapeutics market.
Which Companies Hold the Largest Share Across Different Liver Diseases Therapeutics Market Segments?
Major companies operating in the liver diseases therapeutics market are Astellas Pharma Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, Merck & Co. Inc., Novartis AG, GlaxoSmithKline PLC, Abbott Laboratories Inc., Pfizer Inc., Sanofi SA, Johnson & Johnson Services Inc., Bayer AG, AbbVie Inc., Takeda Pharmaceutical Company Limited, Valeant Pharmaceuticals, Watson Pharmaceuticals Inc., AstraZeneca PLC, Gilead Sciences Inc., Endo International PLC, Alnylam Pharmaceuticals Inc., Provectus Biopharmaceuticals Inc., Intercept Pharmaceuticals Inc., Conatus Pharmaceuticals Inc., CymaBay Therapeutics Inc., Viking Therapeutics Inc., Madrigal Pharmaceuticals Inc., NGM Biopharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., Dicerna Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Enanta Pharmaceuticals Inc.
What Trends Are Driving Growth in The Liver Diseases Therapeutics Market?
The evolution of strategic alliances is a noteworthy trend gaining traction in the liver disease therapeutics market. Renowned firms functioning in the liver disease therapy sphere are pursuing collaborations to fortify their stake in the market. For instance, in January 2022, Aligos Therapeutics Inc., a clinical-stage biopharmaceutical establishment based in the US, formed an alliance with Merck & Co, a firm also originating from the US that specializes in liver disease therapeutics. The objective behind this collaboration is to pioneer and advance oligonucleotide treatments for non-alcoholic steatohepatitis.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/liver-diseases-therapeutics-global-market-report
What Are the Emerging Geographies for The Liver Diseases Therapeutics Market Growth?
North America was the largest region in the liver diseases therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the liver diseases therapeutics market report during the forecast period. The regions covered in the liver diseases therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Liver Diseases Therapeutics Market?
2. What is the CAGR expected in the Liver Diseases Therapeutics Market?
3. What Are the Key Innovations Transforming the Liver Diseases Therapeutics Industry?
4. Which Region Is Leading the Liver Diseases Therapeutics Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Elevating Prevalence Of Liver Diseases Fuels Growth In Liver Disease Therapeutics Market: Key Factor Driving The Growth In The Liver Diseases Therapeutics Market here
News-ID: 3970848 • Views: …
More Releases from The Business Research Company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Liver
Rising Liver Disease Cases Drive Growth In Liver Metastases Treatment Market Dri …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Liver Metastases Treatment Market Size By 2025?
The market for treating liver metastases has seen significant growth in the past few years. It is projected to increase from $1.57 billion in 2024 to $1.71 billion in 2025, with a compound annual growth rate (CAGR) of…
LivCare Liver Support
The liver plays a crucial role in maintaining overall well-being, performing essential functions like detoxification, digestion, and metabolism. However, many people overlook the importance of liver health until problems arise. LivCare Liver Support is a premium supplement designed to keep your liver in peak condition. By incorporating this supplement into your daily routine, you can help ensure your liver functions optimally, leading to better overall health.
● Product Name - LivCare…
Liver Cancer Therapeutics Market - Empowering Recovery, Restoring Health: Innova …
Newark, New Castle, USA - new report, titled Liver Cancer Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Liver Cancer Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Liver Cancer Therapeutics market. The report offers an overview of…
Liver Health Supplements Market Grows Strong as Consumers Adopt Proactive Measur …
Global liver health supplements market was valued at US$ 8.7 Bn in 2021, is growing at an estimated CAGR of 5.8% over the forecast period (2022 - 2030). The liver health supplements market is growing due to the increasing awareness of the importance of liver health and the rise of lifestyle-related liver diseases. The market offers a wide range of supplements that help in improving liver function, supporting liver detoxification,…
Urgent Liver 911 Reviews 2021: Is Urgent Liver 911 Legit?
Urgent Liver 911 by PhytAge Laboratories is a powerful diet that promotes liver function by combining natural minerals and nutrients. The diet is made up of plant and herbal extracts that collectively aid in liver cell protection. While the liver is an important human organ that promotes general health and vitality, most people are unaware that even those who appear to be in good health can be affected by liver…
Liver Extract Power Exporter, Liver Extract Product, Liver Extract Crude, Liver …
Titan Biotech is an ISO 9001:2000 Certified Company, established with an objective of serving Scientific Community and providing good quality of Biological Products, Biotechnology Products, Biological Extracts and their derivatives. Liver Extract Power Exporter is produced from specific fraction of beef liver. Liver Extract is rich in vital nutrients including energy producing B Vitamins and serve as an excellent source of proteins. Liver Extract is capable of stimulating the production…
